DexCom
DXCM
273 hedge funds and large institutions have $5.96B invested in DexCom in 2017 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 112 reducing their positions, and 59 closing their positions.
106% more call options, than puts
Call options by funds: $31.8M | Put options by funds: $15.4M
20% more capital invested
Capital invested by funds: $4.97B → $5.96B (+$987M)
7.53% more ownership
Funds ownership: 470.43% → 477.97% (+7.5%)
3% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 59
1% less funds holding
Funds holding: 275 → 273 (-2)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 112
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$286M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$177M |
| 3 |
Morgan Stanley
New York
|
+$73.2M |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$48.1M |
| 5 |
BM
Bridger Management
New York
|
+$44.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$225M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$85.6M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$58.4M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$47.8M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$26.7M |
DXCM Hedge Fund Activity: Q4 2017 in Review
273 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2017, worth a combined $5.96B — up 20% from $4.97B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new DXCM positions and 59 closed out — a net gain of 2 holders — while 73 added to existing stakes and 112 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $286M. The largest seller was Fidelity Investments, cutting an estimated $225M.
- 273 institutional investors held DexCom (DXCM) as of Q4 2017, down from 275 in Q3 2017.
- Funds reported $5.96B of DexCom stock for Q4 2017, up 20% quarter-over-quarter.
- 61 funds opened new DexCom positions in Q4 2017 and 59 closed out, a net change of +2 holders.
- The largest DexCom buyer in Q4 2017 was T. Rowe Price Associates, an estimated $286M added.
- The largest DexCom seller in Q4 2017 was Fidelity Investments, an estimated $225M sold.
Based on aggregated 13F filings for Q4 2017.